New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Telix, Transcenta.

BioWorld Asia briefs for April 7, 2026

Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Cocrystal, Context, Fore, Eli Lilly, Merck, Ultragenyx, Zeto.

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Adagene, Axsome, Boston Scientific, BSM, Ellipsys, Gilead, Incyte, Lupin, Oncotelics, Phil, Shionogi, Takeda, Tanabe, Techforce, Tenpoint, Valencia, Visufarma.

Clinical updates for biopharma and med tech, including data readouts and publications: Adagene, Alto Neuroscience, Astrazeneca, Beam, Immunovant, Lipocine, Neutrolis, Novo Nordisk, Pangia, Puretech, Seaport, Soligenix, Vascarta.

Biopharma and med-tech companies raising money in public or private financings, including: Adagene, Arch Biopartners, Celldex, Entera, Hoth, Inovio, Stairmed.

New hires and promotions in the biopharma and med-tech industries, including: Akebia, Clarametyx, Coya, Curve, Harmony, Royal, Orionis, Pavmed, Telix.

The top 10 biopharma stock gainers and losers for the week.

These graphs compare the performance of the biotech stocks for all of 2026 using the BioWorld Stock Indicator and the Nasdaq Biotech Index.

Year-to-date money raised in public, private and other financings of biopharma companies.